Resveratoral Protects Against Angiotensin II-Induced Cellular Hypertrophy through Inhibition of CYP1B1/Mid-Chain Hydroxyeicosatetraenoic Acid Mechanism

被引：0
|
作者：
Shoieb, Sherif M. [1 ]
El-Kadi, Ayman O. S. [1 ]
机构：
[1] Univ Alberta, Fac Pharm & Pharmaceut Sci, Edmonton, AB, Canada
来源：
FASEB JOURNAL | 2019年 / 33卷
基金：
加拿大健康研究院;
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
817.3
引用
收藏
页数：2
相关论文
共 50 条
  • [31] MiR-133b-3p attenuates angiotensin II-induced cardiac hypertrophy through the inhibition of apoptosis by targeting CDIP1
    Gu, Jiwei
    Li, Zhen
    Li, Xinyi
    Yang, Ziyao
    Xu, Xi
    Wang, Yanjia
    Li, Xiaohan
    Qin, Kaiyue
    Li, Guizhong
    Xue, Li
    Yang, Xiaoling
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2025, 57 (06):
  • [32] CircHelz inhibition protects against angiotensin II-induced cardiac fibrosis via miR-29b modulation
    Wang, Yixiong
    Tao, Feng
    Xiao, Chuanyu
    Zhang, Wei
    Xie, Qiang
    Guo, Chuanlong
    Tu, Jiancheng
    INDIAN JOURNAL OF BIOCHEMISTRY & BIOPHYSICS, 2025, 62 (01): : 7 - 16
  • [33] Cytochrome P450 (CYP) 1B1-Estradiol Metabolite 2-Methoxyestradiol Protects Against Angiotensin II-induced Hypertension By Inhibiting CYP4A1 Expression <And> 20-Hydroxyeicosatetraenoic Acid (20-HETE) Production In The Female Mice
    Song, Chi Young
    Shin, Ji Soo
    Lew, Jessica
    Falck, John
    Malik, Kafait
    HYPERTENSION, 2019, 74
  • [34] Overexpression of microRNA-26b attenuates angiotensin II-induced cardiac hypertrophy through inhibition of autophagic responses
    Yu, Rong
    Xiang, Zheng
    Zhou, Yongmei
    Huang, Hui
    Zeng, Jie
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (09): : 9409 - 9417
  • [35] Granzyme B Deficiency Protects Against Angiotensin II-induced Cardiac Fibrosis via a Perforin-independent Mechanism
    Shen, Yue
    Cheng, Fang
    Sharma, Mehul
    Merkulova, Yulia
    Raithatha, Sheetal A.
    Parkinson, Leigh G.
    Zhao, Hongyan
    Westendori, Kathryn
    Bohunek, Lubos
    Bozin, Tatjana
    Hsu, Ivy
    Ang, Lisa S.
    Williams, Sarah J.
    Bleackley, R. C.
    Eriksson, John E.
    Seidman, Michael A.
    McManus, Bruce M.
    Granville, David J.
    CIRCULATION, 2015, 132
  • [36] Modulation of Angiotensin II-Induced Cellular Hypertrophy by Cannflavin-C: Unveiling the Impact on Cytochrome P450 1B1 and Arachidonic Acid Metabolites
    Alammari, Ahmad H.
    Isse, Fadumo Ahmed
    O'Croinin, Conor
    Davies, Neal M.
    El-Kadi, Ayman O. S.
    DRUG METABOLISM AND DISPOSITION, 2024, 52 (08) : 875 - 885
  • [37] 6-Formylindolo[3,2-b]carbazole Protects Against Angiotensin II-Induced Cellular Hypertrophy through the Induction of Cytochrome P450 1A1 and Its Associated 19(S)-HETE Metabolite In Vitro
    Alammari, Ahmad H.
    Gerges, Samar H.
    Isse, Fadumo Ahmed
    El-Kadi, Ayman O. S.
    DRUG METABOLISM AND DISPOSITION, 2023, 51 (07) : 833 - 843
  • [38] B1-kinin receptor antagonism reduces the angiotensin II-induced hypertrophy in aorta of rats
    Ceravolo, G. S.
    Dossantos, R. A.
    Tostes, R. C.
    Fortes, Z. B.
    Carvalho, M. H. C.
    JOURNAL OF HYPERTENSION, 2008, 26 : S519 - S519
  • [39] Direct evidence for increased angiotensin II-induced cardiac angiotensin II type hydroxyl radicals in hypertrophy through 1a receptor
    Kakishita, M
    Nakamura, K
    Asanuma, M
    Morita, H
    Saito, H
    Kusano, K
    Nakamura, Y
    Emori, T
    Matsubara, H
    Sugaya, T
    Ogawa, N
    Ohe, T
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2003, 42 : S67 - S70
  • [40] Direct evidence for increased hydroxyl radicals in angiotensin II-induced cardiac hypertrophy through angiotensin II type 1a receptor
    Kakishita, M
    Nakamura, K
    Saito, H
    Nakamura, Y
    Morita, H
    Kusano, K
    Emori, T
    Matsubara, H
    Ohe, T
    CIRCULATION, 2001, 104 (17) : 231 - 231
12345